Dr. Khanani shares the case of a neovascular nAMD patient with high disease activity who achieved significant vision improvement and fluid resolution after switching to faricimab.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.